Anheuser-Busch InBev, the world’s largest brewer, closed Monday on its more than $100 billion acquisition of rival SABMiller.
The top two brewers confirmed plans to merge in November after years of speculation. London-based SABMiller makes Redd’s and Fosters, among other brands, and A-B InBev’s brands include Bud Light, Budweiser and Stella Artois.
The combined company has $55 billion in annual sales and an estimated global market share of 28 percent, according to market research firm Euromonitor International.
With the merger, A-B InBev will a stronger presence in key emerging regions with attractive growth prospects, such as Africa and Latin America, the brewer said Monday.
“As a truly global brewer, we will be able to achieve more together than each of us could separately,” CEO Carlos Brito said in a statement.
To receive regulatory approval in the US SABMiller gave up ownership of the Miller brands by selling its 58 percent stake in MillerCoors to Molson Coors for $12 billion. Previously, MillerCoors was owned by SABMiller and Denver-based Molson Coors in a joint venture.
Full Content: Chicago Tribune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas